- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Dec 3, 2021 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Dec 3, 2021 | T-236-21 | MED | The Incorporated D.b.a The Tragically Hip V. Trillium Beverage (Trade Mark) | Toronto | 1 d |
| Dec 3, 2021 | T-379-18 | CMC | Gentec Et Al V. Nuheara Ip Pty Ltd Et Al (Trade Mark) | Montréal | 1 h |
| Dec 6, 2021 | T-1887-19 | JR | Advanced Purification Engineering Corp. Dba Apec Water Systems V. Ispring Wa (Trade Mark - JR) | Toronto | 1 d |
| Dec 6, 2021 | T-1531-20 | CMC | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 30 m |
| Dec 6, 2021 | T-1533-20 | CMC | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 30 m |
| Dec 6, 2021 | T-1308-20 | CMC | Dermaspark Products Inc. Et Al V. Binal Patel Et Al (Copyright) | Toronto | 1 h |
| Dec 6, 2021 | T-769-20 | TMC | Janssen Inc. Et Al. V. Jamp Pharma Corporation (Patent - Macitentan*) | Toronto | 1 h |
| Dec 6, 2021 | T-962-21 | CMC | Sandoz Canada Inc. V. Hoffmann-la Roche Limited Et Al (Patent) | Toronto | 30 m |
| Dec 8, 2021 | T-1176-21 | JR | Nathan Kruljac V. Minister Of Health (unknown - JR) | Ottawa | 3 h |
| Dec 9, 2021 | T-419-20 | MED | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 7.5 h |
| Dec 9, 2021 | T-449-17 | M | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Saskatoon | 2 h |
| Dec 9, 2021 | T-359-20 | M | Autoscan Gmbh Et Al. V. 5121175 Manitoba Ltd D/b/a Dcc Hail (Copyright) | Montréal | 2 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Jan 10, 2022 | T-1420-18 | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 25 d |
| Jan 10, 2022 | T-419-20 | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jan 10, 2022 | T-1591-15 | Energizer Brands, Llc Et Al. V. The Gillette Company Et Al (Trade Mark) | Toronto | 10 d |
| Jan 10, 2022 | T-567-20 | Ncs Multistage Inc. V. Promac Industries Ltd. (Patent) | Calgary | 25 d |
| Jan 24, 2022 | T-549-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 7 d |
| Jan 24, 2022 | T-509-21 | Ojo Labs, Inc. Et Al V. Re/max Community Inc (Trade Mark) | Toronto | 5 d |
| Jan 25, 2022 | T-1591-15 | Energizer Brands, Llc Et Al. V. The Gillette Company Et Al (Trade Mark) | Toronto | 1 d |
| Feb 2, 2022 | T-419-20 | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 1 d |
| Feb 7, 2022 | T-555-20 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Apixaban*) | Toronto | 5 d |
| Feb 14, 2022 | T-1066-17 | T-rex Property Ab V. Pattison Outdoor Advertising Limited Partnership Et Al (Patent) | Toronto | 15 d |
| Feb 14, 2022 | T-1420-18 | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 2 d |
| Feb 14, 2022 | T-1935-13 | Bernard Charles Sherman Et Al V. Pharmascience Inc (Patent - Quinapril*) | Toronto | 10 d |
| Feb 14, 2022 | T-567-20 | Ncs Multistage Inc. V. Promac Industries Ltd. (Patent) | Calgary | 2 d |
| Feb 17, 2022 | T-549-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 2 d |
| Feb 28, 2022 | T-555-20 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Apixaban*) | Toronto | 2 d |
| Feb 28, 2022 | T-560-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-561-20 | Merck Sharp & Dohme Corp. Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-563-20 | Merck Sharp & Dohme Corp. Et Al V Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 14, 2022 | T-1662-17 | Crocs Canada, Inc. And Crocs Inc. V. Double Diamond Distribution Ltd. (Trade Mark) | Ottawa | 6 d |
| Mar 21, 2022 | T-1769-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 25 d |
| Mar 21, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 25 d |
| Mar 28, 2022 | T-667-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 28, 2022 | T-798-20 | Opiant Pharmaceuticals Inc. Et Al V. Teva Canada Ltd. (Patent - Naloxone*) | Toronto | 10 d |
| Mar 28, 2022 | T-1187-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Apr 4, 2022 | T-769-20 | Janssen Inc. Et Al. V. Jamp Pharma Corporation (Patent - Macitentan*) | Toronto | 10 d |
| Apr 25, 2022 | T-671-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| May 30, 2022 | T-2009-19 | Samsung Bioepis Co.,ltd. V. Fresenius Kabi Deutschlandf Gmbh (Patent - Adalimumab*) | Toronto | 10 d |
| Jun 6, 2022 | T-13-20 | Andritz Ltd Et Al. V. Cortex North America Corporation (Patent) | Montréal | 12 d |
| Jun 6, 2022 | T-891-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Jamp Pharma Corporation (Patent - Lurasidone*) | Toronto | 10 d |
| Jun 13, 2022 | T-1569-18 | Valard Construction Ltd. Et Al V. Acuity Digital Inspection Inc. (Patent) | Calgary | 10 d |
| Jun 13, 2022 | T-952-20 | Google Llc V. Sonos, Inc. (Patent) | Toronto | 10 d |
| Jul 4, 2022 | T-601-20 | Merck Sharp & Dohme Corp Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-602-20 | Merck Sharp & Dohme Corp. Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-668-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-673-20 | Merck Sharp & Dohme Corp. Et Al V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-1441-20 | Janssen Inc. Et Al V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Jul 5, 2022 | T-1207-20 | Pfizer Canada Ulc Et Al. V. Jamp Pharma Corporation (Patent - Tofacitinib*) | Toronto | 9 d |
| Aug 2, 2022 | T-1268-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc (Patent - Canagliflozin*) | Toronto | 10 d |
| Aug 8, 2022 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Toronto | 20 d |
| Aug 15, 2022 | T-604-19 | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Calgary | 15 d |
| Sep 6, 2022 | T-251-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 6, 2022 | T-252-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 12, 2022 | T-202-17 | Travel Leaders Group, Llc V. 204293 Ontario Inc. Dba Travel Leaders (Trade Mark) | Toronto | 10 d |
| Sep 12, 2022 | T-16-21 | Boehringer Ingelheim (canada)ltd. Et Al V. Sandoz Canada Inc. (Patent - Linagliptin*) | Toronto | 15 d |
| Sep 21, 2022 | T-1049-18 | Re/max, Llc V. Save Max Real Estate, Inc. Et Al. (Trade Mark) | Vancouver | 13 d |
| Sep 26, 2022 | T-124-21 | Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Sep 29, 2022 | T-251-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 2 d |
| Sep 29, 2022 | T-252-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 2 d |
| Oct 17, 2022 | T-592-21 | Astrazeneca Canada Inc. Et Al V. Teva Canada Limited (Patent - Dapagliflozin*) | Toronto | 10 d |
| Oct 24, 2022 | T-800-17 | Bell Canada Et Al. V. Adam Lackman Et Al. (Copyright) | Montréal | 4 d |
| Oct 31, 2022 | T-800-17 | Bell Canada Et Al. V. Adam Lackman Et Al. (Copyright) | Montréal | 1 d |
| Oct 31, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 9 d |
| Nov 14, 2022 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 11 d |
| Nov 14, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-1686-18 | Wheel Monitor Inc. V. Cleral Inc. Et Al (Patent) | Toronto | 10 d |
| Nov 14, 2022 | T-1531-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-1533-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Toronto | 20 d |
| Nov 14, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Toronto | 20 d |
| Nov 14, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Toronto | 20 d |
| Nov 14, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Toronto | 20 d |
| Nov 14, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 30, 2022 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 1 d |
| Dec 5, 2022 | T-1213-21 | Lundbeck Canada Inc. And H.lundbeck V. Apotex Inc. Et Al (Patent) | Toronto | 10 d |
| Dec 5, 2022 | T-373-21 | Bristol-myers Squibb Canada Co Et Al V. Sun Pharma Canada Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Dec 5, 2022 | T-668-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent) | Toronto | 10 d |
| Dec 13, 2022 | T-592-21 | Astrazeneca Canada Inc. Et Al V. Teva Canada Limited (Patent - Dapagliflozin*) | Toronto | 1 d |
| Dec 15, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 1 d |
| Dec 19, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Jan 9, 2023 | T-1007-20 | Medexus Pharmaceuticals Inc. Et Al. V. Accord Healthcare Inc. Et Al (Patent) | Ottawa | 14 d |
| Jan 16, 2023 | T-249-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jan 16, 2023 | T-250-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 27, 2023 | T-788-21 | Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 15 d |
| Apr 11, 2023 | T-711-20 | Bell Canada V. Skychoice Communications Inc. (Trade Mark) | Toronto | 8 d |
| Jun 19, 2023 | T-607-21 | Apotex Inc. V. Janssen Inc. Et Al. (Patent) | Toronto | 10 d |
| Jul 10, 2023 | T-1472-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent) | Toronto | 15 d |
| Jul 10, 2023 | T-1475-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent) | Toronto | 15 d |
| Oct 30, 2023 | T-962-21 | Sandoz Canada Inc. V. Hoffmann-la Roche Limited Et Al (Patent) | Toronto | 9 d |
| Nov 17, 2023 | T-962-21 | Sandoz Canada Inc. V. Hoffmann-la Roche Limited Et Al (Patent) | Toronto | 1 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Dec 6, 2021 | T-1887-19 | Advanced Purification Engineering Corp. Dba Apec Water Systems V. Ispring Wa | Trade Mark Opposition | Toronto | 1 d |
| Dec 8, 2021 | T-1176-21 | Nathan Kruljac V. Minister Of Health | S. 18.1 Application for Judicial Review | Ottawa | 3 h |
| Dec 13, 2021 | T-1047-21 | Catalyst Pharmaceuticals, Inc. Et Al. V. Attorney General Of Canada Et Al. | S. 18.1 Application for Judicial Review | Toronto | 3 d |
| Jan 10, 2022 | T-1548-20 | 1196278 Ontario Inc. D.b.a. Sassafraz V. 815470 Ontario Ltd. D.b.a. Sassaf.. | Intellectual Property - Other Applications under the Rules | Toronto | 4 h |
| Jan 11, 2022 | T-1195-21 | Nia Wine Group Co., Ltd. V. North 42 Degrees Estate Winery Inc. | Trade Mark - Appeal of a decision of the Registrar | Ottawa | 3 h |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.